Home » Stocks » EDAP

EDAP TMS S.A. (EDAP)

Stock Price: $9.10 USD -0.44 (-4.61%)
Updated Feb 26, 2021 4:00 PM EST - Market closed
After-hours: $9.15 +0.05 (0.55%) Feb 26, 7:59 PM
Market Cap 268.10M
Revenue (ttm) 50.46M
Net Income (ttm) 1.70M
Shares Out 29.02M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE 23.53
Dividend n/a
Dividend Yield n/a
Trading Day February 26
Last Price $9.10
Previous Close $9.54
Change ($) -0.44
Change (%) -4.61%
Day's Open 9.25
Day's Range 8.83 - 9.50
Day's Volume 416,017
52-Week Range 1.46 - 10.68

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 month ago

LYON, France, January 19, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, today announced that Marc Oczachowski, President and CEO, wil...

GlobeNewsWire - 1 month ago

LYON, France, January 14, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, announced today positive 24 month interim results from the “H...

Zacks Investment Research - 1 month ago

EDAP TMS (EDAP) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

GlobeNewsWire - 1 month ago

Recaps progress made in 2020 notwithstanding the ongoing COVID-19 pandemic and previews anticipated 2021 milestones

GlobeNewsWire - 1 month ago

LYON, France, January 5, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, today announced that it will participate in the 10th Annual Li...

GlobeNewsWire - 1 month ago

LYON, France, December 30, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy- based therapies, announced today two new Focal One sales to leading U.S. hea...

GlobeNewsWire - 2 months ago

Final rules establish, for the first time, a Category 1 CPT code and reimbursement to physicians performing ablation of malignant prostate tissue with HIFU in the US

Seeking Alpha - 3 months ago

EDAP TMS S.A. (EDAP) CEO Marc Oczachowski on Q3 2020 Results - Earnings Call Transcript

Benzinga - 3 months ago

Shares of Edap TMS (NASDAQ:EDAP) were flat after the company reported Q3 results. Quarterly Results Earnings per share decreased 233.33% over the past year to ($0.04), which missed the estimat...

GlobeNewsWire - 3 months ago

 Generated strongest total revenue quarter of 2020

GlobeNewsWire - 3 months ago

LYON, France, November 17, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, announced today that the company has signed an exclusive dis...

GlobeNewsWire - 3 months ago

LYON, France, November 10, 2020 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that management will be presenting at the Jefferies Virtual ...

GlobeNewsWire - 3 months ago

Company to host conference call and webcast on Thursday, November 19 at 8:30 am EDT

Seeking Alpha - 4 months ago

Knifeless Surgery: Prospects And Competition For EDAP

Zacks Investment Research - 4 months ago

As of late, it has definitely been a great time to be an investor in EDAP TMS.

Seeking Alpha - 5 months ago

The company offers an innovative device that produces non-invasive HIFA treatment for prostate cancer with other applications to follow.

GlobeNewsWire - 5 months ago

Call to be Held Tuesday, September 22nd @ 8am Eastern Time

Zacks Investment Research - 5 months ago

As of late, it has definitely been a great time to be an investor EDAP TMS.

GlobeNewsWire - 5 months ago

LYON, France, September 9, 2020 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that management will be presenting at the HC Wainwright Virt...

GlobeNewsWire - 5 months ago

      

Seeking Alpha - 5 months ago

EDAP TMS S.A. (EDAP) CEO Marc Oczachowski on Q2 2020 Results - Earnings Call Transcript

GlobeNewsWire - 6 months ago

LYON, France, August 26, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), the global leader in robotic energy based therapies, announced today financial results for the second quarter of 20...

GlobeNewsWire - 6 months ago

LYON, France, August 25, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the company has received approval from Fr...

GlobeNewsWire - 6 months ago

Company to host conference call and webcast on Thursday, August 27 at 8:30 am EDT

GlobeNewsWire - 6 months ago

 Studies conducted at the University of Southern California and University of Miami represent the first U.S. publications detailing successful partial-gland ablation using high intensity focus...

Zacks Investment Research - 7 months ago

EDAP TMS (EDAP) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

GlobeNewsWire - 7 months ago

LYON, France, July 15, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today provided an update on recent sales successes that occurred...

GlobeNewsWire - 7 months ago

 LYON, France, June 30, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, announced today that veteran medical technology executive Marie...

GlobeNewsWire - 8 months ago

LYON, France, May 28, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, announced today the appointment of Frank Van Hyfte as Vice Presid...

Seeking Alpha - 9 months ago

EDAP Shares Are Still A Steal, But The Pandemic Could Be A Wrench

Seeking Alpha - 9 months ago

EDAP TMS S.A. (EDAP) CEO Marc Oczachowski on Q1 2020 Results - Earnings Call Transcript

GlobeNewsWire - 9 months ago

LYON, France, May 13, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), the global leader in robotic energy based therapies, announced today financial results for the first quarter of 2020 a...

GlobeNewsWire - 9 months ago

LYON, France, May 12, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, announced today that the company has signed an exclusive worldwid...

Seeking Alpha - 10 months ago

EDAP TMS S.A. (EDAP) CEO Marc Oczachowski on Q4 2019 Results - Earnings Call Transcript

GlobeNewsWire - 10 months ago

LYON, France, March 30, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, announced today financial results for the fourth quarter and fu...

GlobeNewsWire - 11 months ago

LYON, France, March 17, 2020 – EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today issued the following letter to shareholders:  

GlobeNewsWire - 1 year ago

LYON, France, February 18, 2020 – EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the company recently showcased its Focal...

GlobeNewsWire - 1 year ago

EDAP Announces Sale of Robotic Focal One® HIFU Device to University of Miami

GlobeNewsWire - 1 year ago

Recaps significant progress made in 2019 and previews expectations for accelerating global growth in 2020

GlobeNewsWire - 1 year ago

Study confirms feasibility of using Focal One HIFU to treat rectal endometriosis

GlobeNewsWire - 1 year ago

LYON, France, November 26, 2019 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in therapeutic ultrasound, announced today that the first Focal One® treatment was performed at...

Zacks Investment Research - 1 year ago

EDAP TMS S.A. (EDAP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Seeking Alpha - 1 year ago

EDAP TMS S.A. (EDAP) CEO Marc Oczachowski on Q3 2019 Results - Earnings Call Transcript

GlobeNewsWire - 1 year ago

LYON, France, November 13, 2019 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in therapeutic ultrasound, announced today financial results for the third quarter and nine mon...

Seeking Alpha - 1 year ago

The company is in the first inning with its HIFU treatment of prostate cancer, enjoying near triple-rate growth in Q2.

Zacks Investment Research - 1 year ago

As of late, it has definitely been a great time to be an investor EDAP TMS.

Zacks Investment Research - 1 year ago

Top Ranked Momentum Stocks to Buy for September 20th

Other stocks mentioned: ECOR, ESTC
Zacks Investment Research - 1 year ago

As of late, it has definitely been a great time to be an investor in EDAP TMS S.A. (EDAP).

Zacks Investment Research - 1 year ago

EDAP TMS S.A. (EDAP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects.

Seeking Alpha - 1 year ago

EDAP TMS S.A. (EDAP) CEO Marc Oczachowski on Q2 2019 Results - Earnings Call Transcript

About EDAP

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. It operates in two divisions, High Intensity Focused Ultrasound (HIFU) and Urological Devices and Services (UDS). The HIFU division develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment offers Ablatherm, an ultrasound guided r... [Read more...]

Industry
Medical Devices
IPO Date
Jul 31, 1997
CEO
Marc Oczachowski
Employees
216
Stock Exchange
NASDAQ
Ticker Symbol
EDAP
Full Company Profile

Financial Performance

Financial numbers in millions EUR.
Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for EDAP TMS S.A. stock is "Buy." The 12-month stock price forecast is 12.67, which is an increase of 39.23% from the latest price.

Price Target
$12.67
(39.23% upside)
Analyst Consensus: Buy